Dermatological Disorders
An Introduction to Dermatological disorders
Dermatological disorders, also known as skin disorders or skin conditions, encompass a wide range of medical conditions that affect the skin, hair, nails and mucous membranes. These disorders can vary widely in terms of their causes, symptoms, severity and treatments. Some common dermatological disorders include acne, atopic dermatitis (i.e. eczema), psoriasis, rosacea, urticaria, vitiligo, fungal infections, skin cancer, hair loss, excessive sweating and ichthyosis. Accurate diagnosis and appropriate treatment are essential for managing these conditions and promoting skin health. The treatment of many of these conditions may require a multidisciplinary approach, particularly in addressing the psychological aspects of some of these conditions.
Our supporting partners do not constitute an endorsement of the content on this page.
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.
In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.
The International Society of Dermatology (ISD) stands at the forefront of advancing global skin health through education, collaboration and outreach.1 Established with a mission to bridge disparities in dermatological care worldwide, the ISD has become a vital hub for connecting ...
In September 2024, a new president took the helm of the European Academy of Dermatology and Venereology (EADV). With this new chapter, we wanted to hear her thoughts on a congress we all know and value—as well as what her ...
Renowned for his work in urticaria, drug allergies and angioedema, Professor Luis FC Ensina is a distinguished allergologist. As a Professor of the Division of Allergy, Clinical Immunology and Rheumatology at the Federal University of São Paulo, Brazil and ...
Treating moderate-to-severe atopic dermatitis in children and adolescents: Insights from the experts
Watch expert dermatologists discuss the management of moderate-to-severe AD in children and adolescents.
The touchDERMATOLOGY team has carefully reviewed leading publications to present the highlights of the most intriguing and influential studies from leading journals.
We’re looking forward to the upcoming 2024 AAD Annual Meeting which is taking place in San Diego between 8-12 March 2024. Promising attendees an opportunity to explore the latest technologies, treatments and products in the field of dermatology, we are excited ...
Dr. James Del Rosso (JDR Dermatology Research, Las Vegas, Nevada, USA, and President-Elect American Acne & Rosacea Society) discusses the efficacy and safety results from the CAMP-1 and CAMP-2 studies, highlighting their role in supporting the recent FDA approval cantharidin ...
Molluscum contagiosum, a common skin infection caused by a poxvirus (molluscum contagiosum virus), usually resulting in benign, mild skin disease characterized by lesions appearing anywhere on the body. In this interview, Dr. James Del Rosso (JDR Dermatology Research, Las Vegas, ...
TouchDERMATOLOGY coverage from AAD 2023: Personalised medicine utilises biomarkers to predict patient outcomes and responses to treatment, ensuring that patients get the most effective treatment quicker. We were delighted to speak to Expert Faculty member Dr. William Damsky (Yale School of ...
Janus kinase inhibitors (JAKis) have transformed the landscape of dermatological therapy over the last 2 years, with six United States Food and Drug Administration approvals and further clinical trials in progress.1 JAKis have proven highly efficacious in dermatological diseases, by blocking ...
The pathogenesis of cutaneous granulomatous disorders is incompletely understood and many unmet needs remain in the treatment paradigm.1 These disorders can be categorized into two main groups: those caused by infections and those associated with inflammatory skin conditions, among the ...
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
